|
KCTD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47540000217106E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16969999966565E-07 |
| Normal-vs-Stage2 |
4.1190999999996E-05 |
| Normal-vs-Stage3 |
1.73707999999717E-05 |
| Normal-vs-Stage4 |
9.438300E-03 |
| Stage1-vs-Stage2 |
4.943000E-01 |
| Stage1-vs-Stage3 |
5.111000E-01 |
| Stage1-vs-Stage4 |
5.518600E-01 |
| Stage2-vs-Stage3 |
9.140600E-01 |
| Stage2-vs-Stage4 |
9.341400E-01 |
| Stage3-vs-Stage4 |
8.608000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.47530001735208E-09 |
| Normal-vs-AfricanAmerican |
7.6268000000046E-05 |
| Normal-vs-Asian |
2.194200E-02 |
| Caucasian-vs-AfricanAmerican |
3.564600E-01 |
| Caucasian-vs-Asian |
6.599600E-01 |
| AfricanAmerican-vs-Asian |
9.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4501000096584E-09 |
| Normal-vs-Female |
1.99316999999199E-05 |
| Male-vs-Female |
2.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.035000E-04 |
| Normal-vs-Extreme_Weight |
3.0801999950647E-08 |
| Normal-vs-Obese |
2.37549999999587E-05 |
| Normal-vs-Extreme_Obese |
1.225580E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.411200E-01 |
| Normal_Weight-vs-Obese |
8.957400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.234200E-01 |
| Extreme_Weight-vs-Obese |
1.632990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.560200E-01 |
| Obese-vs-Extreme_Obese |
7.442600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.521300E-03 |
| Normal-vs-Age(41-60Yrs) |
5.50800000054252E-07 |
| Normal-vs-Age(61-80Yrs) |
4.81520001649471E-09 |
| Normal-vs-Age(81-100Yrs) |
7.049700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.925800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.909000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.091200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.051800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.634600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.043200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.59990000048982E-07 |
| Normal-VS-Type2 PRCC |
8.43309999609687E-08 |
| Normal-VS-KIRP CIMP |
1.549820E-02 |
| Normal-VS-Unclassified PRCC |
1.39089999995345E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.123830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.589000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.424820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.571700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.489000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.703200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97939997725882E-10 |
| Normal-vs-N1 |
2.796000E-03 |
| Normal-vs-N2 |
1.01210000003071E-06 |
| N0-vs-N1 |
2.191200E-01 |
| N0-vs-N2 |
4.561700E-02 |
| N1-vs-N2 |
6.946300E-02 |
|
|
